Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
20,707
archived clinical trials in
Gastrointestinal

Eosinophilic Esophagitis Databank
Eosinophilic Esophagitis (EoE) Databank (CoFAR 5)
Status: Enrolling
Updated:  3/3/2016
Johns Hopkins University
mi
from
Baltimore, MD
Eosinophilic Esophagitis Databank
Eosinophilic Esophagitis (EoE) Databank (CoFAR 5)
Status: Enrolling
Updated: 3/3/2016
Johns Hopkins University
mi
from
Baltimore, MD
Click here to add this to my saved trials
Eosinophilic Esophagitis Databank
Eosinophilic Esophagitis (EoE) Databank (CoFAR 5)
Status: Enrolling
Updated:  3/3/2016
Univ of North Carolina
mi
from
Chapel Hill, NC
Eosinophilic Esophagitis Databank
Eosinophilic Esophagitis (EoE) Databank (CoFAR 5)
Status: Enrolling
Updated: 3/3/2016
Univ of North Carolina
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Eosinophilic Esophagitis Databank
Eosinophilic Esophagitis (EoE) Databank (CoFAR 5)
Status: Enrolling
Updated:  3/3/2016
Mount Sinai School of Medicine
mi
from
New York, NY
Eosinophilic Esophagitis Databank
Eosinophilic Esophagitis (EoE) Databank (CoFAR 5)
Status: Enrolling
Updated: 3/3/2016
Mount Sinai School of Medicine
mi
from
New York, NY
Click here to add this to my saved trials
Trichuris Suis Ova Treatment in Left-sided Ulcerative Colitis
A Prospective, Randomized, Double-blind, Placebo-controlled Phase II Clinical Study of Trichuris Suis Ova Treatment in Left-sided Ulcerative Colitis and Its Effects on Mucosal Immune State and Microbiota
Status: Enrolling
Updated:  3/3/2016
Stanford University School of Medicine
mi
from
Palo Alto, CA
Trichuris Suis Ova Treatment in Left-sided Ulcerative Colitis
A Prospective, Randomized, Double-blind, Placebo-controlled Phase II Clinical Study of Trichuris Suis Ova Treatment in Left-sided Ulcerative Colitis and Its Effects on Mucosal Immune State and Microbiota
Status: Enrolling
Updated: 3/3/2016
Stanford University School of Medicine
mi
from
Palo Alto, CA
Click here to add this to my saved trials
Trichuris Suis Ova Treatment in Left-sided Ulcerative Colitis
A Prospective, Randomized, Double-blind, Placebo-controlled Phase II Clinical Study of Trichuris Suis Ova Treatment in Left-sided Ulcerative Colitis and Its Effects on Mucosal Immune State and Microbiota
Status: Enrolling
Updated:  3/3/2016
Yale University
mi
from
New Haven, CT
Trichuris Suis Ova Treatment in Left-sided Ulcerative Colitis
A Prospective, Randomized, Double-blind, Placebo-controlled Phase II Clinical Study of Trichuris Suis Ova Treatment in Left-sided Ulcerative Colitis and Its Effects on Mucosal Immune State and Microbiota
Status: Enrolling
Updated: 3/3/2016
Yale University
mi
from
New Haven, CT
Click here to add this to my saved trials
Trichuris Suis Ova Treatment in Left-sided Ulcerative Colitis
A Prospective, Randomized, Double-blind, Placebo-controlled Phase II Clinical Study of Trichuris Suis Ova Treatment in Left-sided Ulcerative Colitis and Its Effects on Mucosal Immune State and Microbiota
Status: Enrolling
Updated:  3/3/2016
University of Miami Miller School of Medicine
mi
from
Miami, FL
Trichuris Suis Ova Treatment in Left-sided Ulcerative Colitis
A Prospective, Randomized, Double-blind, Placebo-controlled Phase II Clinical Study of Trichuris Suis Ova Treatment in Left-sided Ulcerative Colitis and Its Effects on Mucosal Immune State and Microbiota
Status: Enrolling
Updated: 3/3/2016
University of Miami Miller School of Medicine
mi
from
Miami, FL
Click here to add this to my saved trials
Trichuris Suis Ova Treatment in Left-sided Ulcerative Colitis
A Prospective, Randomized, Double-blind, Placebo-controlled Phase II Clinical Study of Trichuris Suis Ova Treatment in Left-sided Ulcerative Colitis and Its Effects on Mucosal Immune State and Microbiota
Status: Enrolling
Updated:  3/3/2016
Northwestern University Feinberg School of Medicine
mi
from
Chicago, IL
Trichuris Suis Ova Treatment in Left-sided Ulcerative Colitis
A Prospective, Randomized, Double-blind, Placebo-controlled Phase II Clinical Study of Trichuris Suis Ova Treatment in Left-sided Ulcerative Colitis and Its Effects on Mucosal Immune State and Microbiota
Status: Enrolling
Updated: 3/3/2016
Northwestern University Feinberg School of Medicine
mi
from
Chicago, IL
Click here to add this to my saved trials
Trichuris Suis Ova Treatment in Left-sided Ulcerative Colitis
A Prospective, Randomized, Double-blind, Placebo-controlled Phase II Clinical Study of Trichuris Suis Ova Treatment in Left-sided Ulcerative Colitis and Its Effects on Mucosal Immune State and Microbiota
Status: Enrolling
Updated:  3/3/2016
University of Chicago
mi
from
Chicago, IL
Trichuris Suis Ova Treatment in Left-sided Ulcerative Colitis
A Prospective, Randomized, Double-blind, Placebo-controlled Phase II Clinical Study of Trichuris Suis Ova Treatment in Left-sided Ulcerative Colitis and Its Effects on Mucosal Immune State and Microbiota
Status: Enrolling
Updated: 3/3/2016
University of Chicago
mi
from
Chicago, IL
Click here to add this to my saved trials
Trichuris Suis Ova Treatment in Left-sided Ulcerative Colitis
A Prospective, Randomized, Double-blind, Placebo-controlled Phase II Clinical Study of Trichuris Suis Ova Treatment in Left-sided Ulcerative Colitis and Its Effects on Mucosal Immune State and Microbiota
Status: Enrolling
Updated:  3/3/2016
University of Iowa Hospital
mi
from
Iowa City, IA
Trichuris Suis Ova Treatment in Left-sided Ulcerative Colitis
A Prospective, Randomized, Double-blind, Placebo-controlled Phase II Clinical Study of Trichuris Suis Ova Treatment in Left-sided Ulcerative Colitis and Its Effects on Mucosal Immune State and Microbiota
Status: Enrolling
Updated: 3/3/2016
University of Iowa Hospital
mi
from
Iowa City, IA
Click here to add this to my saved trials
Trichuris Suis Ova Treatment in Left-sided Ulcerative Colitis
A Prospective, Randomized, Double-blind, Placebo-controlled Phase II Clinical Study of Trichuris Suis Ova Treatment in Left-sided Ulcerative Colitis and Its Effects on Mucosal Immune State and Microbiota
Status: Enrolling
Updated:  3/3/2016
University of Maryland
mi
from
Baltimore, MD
Trichuris Suis Ova Treatment in Left-sided Ulcerative Colitis
A Prospective, Randomized, Double-blind, Placebo-controlled Phase II Clinical Study of Trichuris Suis Ova Treatment in Left-sided Ulcerative Colitis and Its Effects on Mucosal Immune State and Microbiota
Status: Enrolling
Updated: 3/3/2016
University of Maryland
mi
from
Baltimore, MD
Click here to add this to my saved trials
Trichuris Suis Ova Treatment in Left-sided Ulcerative Colitis
A Prospective, Randomized, Double-blind, Placebo-controlled Phase II Clinical Study of Trichuris Suis Ova Treatment in Left-sided Ulcerative Colitis and Its Effects on Mucosal Immune State and Microbiota
Status: Enrolling
Updated:  3/3/2016
Tufts Medical Center
mi
from
Boston, MA
Trichuris Suis Ova Treatment in Left-sided Ulcerative Colitis
A Prospective, Randomized, Double-blind, Placebo-controlled Phase II Clinical Study of Trichuris Suis Ova Treatment in Left-sided Ulcerative Colitis and Its Effects on Mucosal Immune State and Microbiota
Status: Enrolling
Updated: 3/3/2016
Tufts Medical Center
mi
from
Boston, MA
Click here to add this to my saved trials
Trichuris Suis Ova Treatment in Left-sided Ulcerative Colitis
A Prospective, Randomized, Double-blind, Placebo-controlled Phase II Clinical Study of Trichuris Suis Ova Treatment in Left-sided Ulcerative Colitis and Its Effects on Mucosal Immune State and Microbiota
Status: Enrolling
Updated:  3/3/2016
Duke Univ Med Ctr
mi
from
Durham, NC
Trichuris Suis Ova Treatment in Left-sided Ulcerative Colitis
A Prospective, Randomized, Double-blind, Placebo-controlled Phase II Clinical Study of Trichuris Suis Ova Treatment in Left-sided Ulcerative Colitis and Its Effects on Mucosal Immune State and Microbiota
Status: Enrolling
Updated: 3/3/2016
Duke Univ Med Ctr
mi
from
Durham, NC
Click here to add this to my saved trials
Trichuris Suis Ova Treatment in Left-sided Ulcerative Colitis
A Prospective, Randomized, Double-blind, Placebo-controlled Phase II Clinical Study of Trichuris Suis Ova Treatment in Left-sided Ulcerative Colitis and Its Effects on Mucosal Immune State and Microbiota
Status: Enrolling
Updated:  3/3/2016
Cleveland Clinic
mi
from
Cleveland, OH
Trichuris Suis Ova Treatment in Left-sided Ulcerative Colitis
A Prospective, Randomized, Double-blind, Placebo-controlled Phase II Clinical Study of Trichuris Suis Ova Treatment in Left-sided Ulcerative Colitis and Its Effects on Mucosal Immune State and Microbiota
Status: Enrolling
Updated: 3/3/2016
Cleveland Clinic
mi
from
Cleveland, OH
Click here to add this to my saved trials
Trichuris Suis Ova Treatment in Left-sided Ulcerative Colitis
A Prospective, Randomized, Double-blind, Placebo-controlled Phase II Clinical Study of Trichuris Suis Ova Treatment in Left-sided Ulcerative Colitis and Its Effects on Mucosal Immune State and Microbiota
Status: Enrolling
Updated:  3/3/2016
Drexel University
mi
from
Philadelphia, PA
Trichuris Suis Ova Treatment in Left-sided Ulcerative Colitis
A Prospective, Randomized, Double-blind, Placebo-controlled Phase II Clinical Study of Trichuris Suis Ova Treatment in Left-sided Ulcerative Colitis and Its Effects on Mucosal Immune State and Microbiota
Status: Enrolling
Updated: 3/3/2016
Drexel University
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Trichuris Suis Ova Treatment in Left-sided Ulcerative Colitis
A Prospective, Randomized, Double-blind, Placebo-controlled Phase II Clinical Study of Trichuris Suis Ova Treatment in Left-sided Ulcerative Colitis and Its Effects on Mucosal Immune State and Microbiota
Status: Enrolling
Updated:  3/3/2016
University of Pittsburgh
mi
from
Pittsburgh, PA
Trichuris Suis Ova Treatment in Left-sided Ulcerative Colitis
A Prospective, Randomized, Double-blind, Placebo-controlled Phase II Clinical Study of Trichuris Suis Ova Treatment in Left-sided Ulcerative Colitis and Its Effects on Mucosal Immune State and Microbiota
Status: Enrolling
Updated: 3/3/2016
University of Pittsburgh
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Trichuris Suis Ova Treatment in Left-sided Ulcerative Colitis
A Prospective, Randomized, Double-blind, Placebo-controlled Phase II Clinical Study of Trichuris Suis Ova Treatment in Left-sided Ulcerative Colitis and Its Effects on Mucosal Immune State and Microbiota
Status: Enrolling
Updated:  3/3/2016
Vanderbilt University
mi
from
Nashville, TN
Trichuris Suis Ova Treatment in Left-sided Ulcerative Colitis
A Prospective, Randomized, Double-blind, Placebo-controlled Phase II Clinical Study of Trichuris Suis Ova Treatment in Left-sided Ulcerative Colitis and Its Effects on Mucosal Immune State and Microbiota
Status: Enrolling
Updated: 3/3/2016
Vanderbilt University
mi
from
Nashville, TN
Click here to add this to my saved trials
Trichuris Suis Ova Treatment in Left-sided Ulcerative Colitis
A Prospective, Randomized, Double-blind, Placebo-controlled Phase II Clinical Study of Trichuris Suis Ova Treatment in Left-sided Ulcerative Colitis and Its Effects on Mucosal Immune State and Microbiota
Status: Enrolling
Updated:  3/3/2016
Baylor College of Medicine
mi
from
Houston, TX
Trichuris Suis Ova Treatment in Left-sided Ulcerative Colitis
A Prospective, Randomized, Double-blind, Placebo-controlled Phase II Clinical Study of Trichuris Suis Ova Treatment in Left-sided Ulcerative Colitis and Its Effects on Mucosal Immune State and Microbiota
Status: Enrolling
Updated: 3/3/2016
Baylor College of Medicine
mi
from
Houston, TX
Click here to add this to my saved trials
Trichuris Suis Ova Treatment in Left-sided Ulcerative Colitis
A Prospective, Randomized, Double-blind, Placebo-controlled Phase II Clinical Study of Trichuris Suis Ova Treatment in Left-sided Ulcerative Colitis and Its Effects on Mucosal Immune State and Microbiota
Status: Enrolling
Updated:  3/3/2016
Virginia Mason Medical Center
mi
from
Seattle, WA
Trichuris Suis Ova Treatment in Left-sided Ulcerative Colitis
A Prospective, Randomized, Double-blind, Placebo-controlled Phase II Clinical Study of Trichuris Suis Ova Treatment in Left-sided Ulcerative Colitis and Its Effects on Mucosal Immune State and Microbiota
Status: Enrolling
Updated: 3/3/2016
Virginia Mason Medical Center
mi
from
Seattle, WA
Click here to add this to my saved trials
Trichuris Suis Ova Treatment in Left-sided Ulcerative Colitis
A Prospective, Randomized, Double-blind, Placebo-controlled Phase II Clinical Study of Trichuris Suis Ova Treatment in Left-sided Ulcerative Colitis and Its Effects on Mucosal Immune State and Microbiota
Status: Enrolling
Updated:  3/3/2016
The Mayo Clinic
mi
from
Rochester, MN
Trichuris Suis Ova Treatment in Left-sided Ulcerative Colitis
A Prospective, Randomized, Double-blind, Placebo-controlled Phase II Clinical Study of Trichuris Suis Ova Treatment in Left-sided Ulcerative Colitis and Its Effects on Mucosal Immune State and Microbiota
Status: Enrolling
Updated: 3/3/2016
The Mayo Clinic
mi
from
Rochester, MN
Click here to add this to my saved trials
Trichuris Suis Ova Treatment in Left-sided Ulcerative Colitis
A Prospective, Randomized, Double-blind, Placebo-controlled Phase II Clinical Study of Trichuris Suis Ova Treatment in Left-sided Ulcerative Colitis and Its Effects on Mucosal Immune State and Microbiota
Status: Enrolling
Updated:  3/3/2016
Weill-Cornell Medical College
mi
from
New York, NY
Trichuris Suis Ova Treatment in Left-sided Ulcerative Colitis
A Prospective, Randomized, Double-blind, Placebo-controlled Phase II Clinical Study of Trichuris Suis Ova Treatment in Left-sided Ulcerative Colitis and Its Effects on Mucosal Immune State and Microbiota
Status: Enrolling
Updated: 3/3/2016
Weill-Cornell Medical College
mi
from
New York, NY
Click here to add this to my saved trials
Single Incision Laparoscopic Cholecystectomy Using a Flexible Endoscope and Ethicon Manually Articulating Devices (MAD)
Single Incision Laparoscopic Cholecystectomy Using a Flexible Endoscope and Ethicon Manually Articulating Devices (MAD)
Status: Enrolling
Updated:  3/4/2016
St Luke's - Roosevelt Hospital Center
mi
from
New York, NY
Single Incision Laparoscopic Cholecystectomy Using a Flexible Endoscope and Ethicon Manually Articulating Devices (MAD)
Single Incision Laparoscopic Cholecystectomy Using a Flexible Endoscope and Ethicon Manually Articulating Devices (MAD)
Status: Enrolling
Updated: 3/4/2016
St Luke's - Roosevelt Hospital Center
mi
from
New York, NY
Click here to add this to my saved trials
Naltrexone for Opioid Dependent Released Human Immunodeficiency Virus Positive (HIV+) Criminal Justice Populations
Naltrexone for Opioid Dependent Released Human Immunodeficiency Virus Positive (HIV+) Criminal Justice Populations
Status: Enrolling
Updated:  3/7/2016
Yale University
mi
from
Hartford, CT
Naltrexone for Opioid Dependent Released Human Immunodeficiency Virus Positive (HIV+) Criminal Justice Populations
Naltrexone for Opioid Dependent Released Human Immunodeficiency Virus Positive (HIV+) Criminal Justice Populations
Status: Enrolling
Updated: 3/7/2016
Yale University
mi
from
Hartford, CT
Click here to add this to my saved trials
Naltrexone for Opioid Dependent Released Human Immunodeficiency Virus Positive (HIV+) Criminal Justice Populations
Naltrexone for Opioid Dependent Released Human Immunodeficiency Virus Positive (HIV+) Criminal Justice Populations
Status: Enrolling
Updated:  3/7/2016
Yale University
mi
from
New Haven, CT
Naltrexone for Opioid Dependent Released Human Immunodeficiency Virus Positive (HIV+) Criminal Justice Populations
Naltrexone for Opioid Dependent Released Human Immunodeficiency Virus Positive (HIV+) Criminal Justice Populations
Status: Enrolling
Updated: 3/7/2016
Yale University
mi
from
New Haven, CT
Click here to add this to my saved trials
Naltrexone for Opioid Dependent Released Human Immunodeficiency Virus Positive (HIV+) Criminal Justice Populations
Naltrexone for Opioid Dependent Released Human Immunodeficiency Virus Positive (HIV+) Criminal Justice Populations
Status: Enrolling
Updated:  3/7/2016
Baystate Medical Center
mi
from
Springfield, MA
Naltrexone for Opioid Dependent Released Human Immunodeficiency Virus Positive (HIV+) Criminal Justice Populations
Naltrexone for Opioid Dependent Released Human Immunodeficiency Virus Positive (HIV+) Criminal Justice Populations
Status: Enrolling
Updated: 3/7/2016
Baystate Medical Center
mi
from
Springfield, MA
Click here to add this to my saved trials
PK Study of Sotagliflozin in Subjects With Hepatic Impairment
A Phase 1, Open-label, Parallel-group Study to Evaluate the Single-dose Pharmacokinetics of Sotagliflozin in Male and Female Subjects With Mild, Moderate, and Severe Hepatic Impairment and Matched Subjects With Normal Hepatic Function
Status: Enrolling
Updated:  3/7/2016
Lexicon Investigational Site
mi
from
Lakewood, CO
PK Study of Sotagliflozin in Subjects With Hepatic Impairment
A Phase 1, Open-label, Parallel-group Study to Evaluate the Single-dose Pharmacokinetics of Sotagliflozin in Male and Female Subjects With Mild, Moderate, and Severe Hepatic Impairment and Matched Subjects With Normal Hepatic Function
Status: Enrolling
Updated: 3/7/2016
Lexicon Investigational Site
mi
from
Lakewood, CO
Click here to add this to my saved trials
PK Study of Sotagliflozin in Subjects With Hepatic Impairment
A Phase 1, Open-label, Parallel-group Study to Evaluate the Single-dose Pharmacokinetics of Sotagliflozin in Male and Female Subjects With Mild, Moderate, and Severe Hepatic Impairment and Matched Subjects With Normal Hepatic Function
Status: Enrolling
Updated:  3/7/2016
Lexicon Investigational Site
mi
from
Miami, FL
PK Study of Sotagliflozin in Subjects With Hepatic Impairment
A Phase 1, Open-label, Parallel-group Study to Evaluate the Single-dose Pharmacokinetics of Sotagliflozin in Male and Female Subjects With Mild, Moderate, and Severe Hepatic Impairment and Matched Subjects With Normal Hepatic Function
Status: Enrolling
Updated: 3/7/2016
Lexicon Investigational Site
mi
from
Miami, FL
Click here to add this to my saved trials
PK Study of Sotagliflozin in Subjects With Hepatic Impairment
A Phase 1, Open-label, Parallel-group Study to Evaluate the Single-dose Pharmacokinetics of Sotagliflozin in Male and Female Subjects With Mild, Moderate, and Severe Hepatic Impairment and Matched Subjects With Normal Hepatic Function
Status: Enrolling
Updated:  3/7/2016
Lexicon Investigational Site
mi
from
Orlando, FL
PK Study of Sotagliflozin in Subjects With Hepatic Impairment
A Phase 1, Open-label, Parallel-group Study to Evaluate the Single-dose Pharmacokinetics of Sotagliflozin in Male and Female Subjects With Mild, Moderate, and Severe Hepatic Impairment and Matched Subjects With Normal Hepatic Function
Status: Enrolling
Updated: 3/7/2016
Lexicon Investigational Site
mi
from
Orlando, FL
Click here to add this to my saved trials
PK Study of Sotagliflozin in Subjects With Hepatic Impairment
A Phase 1, Open-label, Parallel-group Study to Evaluate the Single-dose Pharmacokinetics of Sotagliflozin in Male and Female Subjects With Mild, Moderate, and Severe Hepatic Impairment and Matched Subjects With Normal Hepatic Function
Status: Enrolling
Updated:  3/7/2016
Lexicon Investigational Site
mi
from
Minneapolis, MN
PK Study of Sotagliflozin in Subjects With Hepatic Impairment
A Phase 1, Open-label, Parallel-group Study to Evaluate the Single-dose Pharmacokinetics of Sotagliflozin in Male and Female Subjects With Mild, Moderate, and Severe Hepatic Impairment and Matched Subjects With Normal Hepatic Function
Status: Enrolling
Updated: 3/7/2016
Lexicon Investigational Site
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Effects of Denosumab on the Pharmacokinetics of Etanercept
The Effects of Denosumab on the Pharmacokinetics of Etanercept in Postmenopausal Women With Low Bone Mineral Density and Rheumatoid Arthritis
Status: Enrolling
Updated:  3/8/2016
Clinical Research Facility
mi
from
Duncansville, PA
Effects of Denosumab on the Pharmacokinetics of Etanercept
The Effects of Denosumab on the Pharmacokinetics of Etanercept in Postmenopausal Women With Low Bone Mineral Density and Rheumatoid Arthritis
Status: Enrolling
Updated: 3/8/2016
Clinical Research Facility
mi
from
Duncansville, PA
Click here to add this to my saved trials
Effects of Denosumab on the Pharmacokinetics of Etanercept
The Effects of Denosumab on the Pharmacokinetics of Etanercept in Postmenopausal Women With Low Bone Mineral Density and Rheumatoid Arthritis
Status: Enrolling
Updated:  3/8/2016
Clinical Research Facility
mi
from
Dallas, TX
Effects of Denosumab on the Pharmacokinetics of Etanercept
The Effects of Denosumab on the Pharmacokinetics of Etanercept in Postmenopausal Women With Low Bone Mineral Density and Rheumatoid Arthritis
Status: Enrolling
Updated: 3/8/2016
Clinical Research Facility
mi
from
Dallas, TX
Click here to add this to my saved trials
Secretin Infusion for Pain Due to Chronic Pancreatitis
Secretin Infusion for Pain Due to Chronic Pancreatitis
Status: Enrolling
Updated:  3/8/2016
Dartmouth Hitchcock Medical Center
mi
from
Lebanon, NH
Secretin Infusion for Pain Due to Chronic Pancreatitis
Secretin Infusion for Pain Due to Chronic Pancreatitis
Status: Enrolling
Updated: 3/8/2016
Dartmouth Hitchcock Medical Center
mi
from
Lebanon, NH
Click here to add this to my saved trials
Extended-Release Naltrexone for Opioid Relapse Prevention Following Release From Jail
Extended-Release Naltrexone for Opioid Relapse Prevention Following Release From Jail
Status: Enrolling
Updated:  3/8/2016
New York University School of Medicine
mi
from
New York, NY
Extended-Release Naltrexone for Opioid Relapse Prevention Following Release From Jail
Extended-Release Naltrexone for Opioid Relapse Prevention Following Release From Jail
Status: Enrolling
Updated: 3/8/2016
New York University School of Medicine
mi
from
New York, NY
Click here to add this to my saved trials
Extended-Release Naltrexone for Opioid Relapse Prevention Following Release From Jail
Extended-Release Naltrexone for Opioid Relapse Prevention Following Release From Jail
Status: Enrolling
Updated:  3/8/2016
New York City Department of Correction
mi
from
New York, NY
Extended-Release Naltrexone for Opioid Relapse Prevention Following Release From Jail
Extended-Release Naltrexone for Opioid Relapse Prevention Following Release From Jail
Status: Enrolling
Updated: 3/8/2016
New York City Department of Correction
mi
from
New York, NY
Click here to add this to my saved trials
Anal Human Papillomavirus in Inflammatory Bowel Disease Study
Characterization of Anal Human Papillomavirus (HPV) Infection in the University of Pittsburgh Inflammatory Bowel Disease (IBD) Cohort Study
Status: Enrolling
Updated:  3/9/2016
University of Pittsburgh
mi
from
Pittsburgh, PA
Anal Human Papillomavirus in Inflammatory Bowel Disease Study
Characterization of Anal Human Papillomavirus (HPV) Infection in the University of Pittsburgh Inflammatory Bowel Disease (IBD) Cohort Study
Status: Enrolling
Updated: 3/9/2016
University of Pittsburgh
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Vitamin D Supplementation on 15-Prostaglandin Dehydrogenase Expression in Barrett's Esophagus
Effect of Vitamin D Supplementation on 15-Prostaglandin Dehydrogenase Expression in Barrett's Esophagus
Status: Enrolling
Updated:  3/9/2016
University Hospitals Ahuja Medical Center
mi
from
Beachwood, OH
Vitamin D Supplementation on 15-Prostaglandin Dehydrogenase Expression in Barrett's Esophagus
Effect of Vitamin D Supplementation on 15-Prostaglandin Dehydrogenase Expression in Barrett's Esophagus
Status: Enrolling
Updated: 3/9/2016
University Hospitals Ahuja Medical Center
mi
from
Beachwood, OH
Click here to add this to my saved trials
Vitamin D Supplementation on 15-Prostaglandin Dehydrogenase Expression in Barrett's Esophagus
Effect of Vitamin D Supplementation on 15-Prostaglandin Dehydrogenase Expression in Barrett's Esophagus
Status: Enrolling
Updated:  3/9/2016
University Hospitals Seidman Cancer Center
mi
from
Cleveland, OH
Vitamin D Supplementation on 15-Prostaglandin Dehydrogenase Expression in Barrett's Esophagus
Effect of Vitamin D Supplementation on 15-Prostaglandin Dehydrogenase Expression in Barrett's Esophagus
Status: Enrolling
Updated: 3/9/2016
University Hospitals Seidman Cancer Center
mi
from
Cleveland, OH
Click here to add this to my saved trials
Vitamin D Supplementation on 15-Prostaglandin Dehydrogenase Expression in Barrett's Esophagus
Effect of Vitamin D Supplementation on 15-Prostaglandin Dehydrogenase Expression in Barrett's Esophagus
Status: Enrolling
Updated:  3/9/2016
Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center
mi
from
Cleveland, OH
Vitamin D Supplementation on 15-Prostaglandin Dehydrogenase Expression in Barrett's Esophagus
Effect of Vitamin D Supplementation on 15-Prostaglandin Dehydrogenase Expression in Barrett's Esophagus
Status: Enrolling
Updated: 3/9/2016
Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center
mi
from
Cleveland, OH
Click here to add this to my saved trials
The Use of Transient Elastography to Predict Clinical Decompensation in Patients With Early Cirrhosis
The Use of Transient Elastography to Predict Clinical Decompensation in Patients With Early Cirrhosis
Status: Enrolling
Updated:  3/9/2016
NYU Langone Medical Center
mi
from
New York, NY
The Use of Transient Elastography to Predict Clinical Decompensation in Patients With Early Cirrhosis
The Use of Transient Elastography to Predict Clinical Decompensation in Patients With Early Cirrhosis
Status: Enrolling
Updated: 3/9/2016
NYU Langone Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
Serine Proteases in Gastrointestinal Function and Irritable Bowel Syndrome (IBS)
The Role of Serine-Proteases in Gastrointestinal Function and Irritable Bowel Syndrome
Status: Enrolling
Updated:  3/10/2016
University of North Carolina at Chapel Hill, Program in Digestive Health and the Department of Gastroenterology and Hepatology
mi
from
Chapel Hill, NC
Serine Proteases in Gastrointestinal Function and Irritable Bowel Syndrome (IBS)
The Role of Serine-Proteases in Gastrointestinal Function and Irritable Bowel Syndrome
Status: Enrolling
Updated: 3/10/2016
University of North Carolina at Chapel Hill, Program in Digestive Health and the Department of Gastroenterology and Hepatology
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Ischemic Foot Ulcers: Is Intervention Better Than Wound Care Alone
Ischemic Foot Ulcers: Is Intervention Better Than Wound Care Alone? A Randomized Controlled Trial
Status: Enrolling
Updated:  3/10/2016
UPMC
mi
from
Pittsburgh, PA
Ischemic Foot Ulcers: Is Intervention Better Than Wound Care Alone
Ischemic Foot Ulcers: Is Intervention Better Than Wound Care Alone? A Randomized Controlled Trial
Status: Enrolling
Updated: 3/10/2016
UPMC
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Therapeutic Hypothermia for Severe Acute Pancreatitis
Therapeutic Hypothermia for Severe Acute Pancreatitis: A Clinical Model for "Suspended Inflammation"
Status: Enrolling
Updated:  3/10/2016
NYU Medical Center
mi
from
New York, NY
Therapeutic Hypothermia for Severe Acute Pancreatitis
Therapeutic Hypothermia for Severe Acute Pancreatitis: A Clinical Model for "Suspended Inflammation"
Status: Enrolling
Updated: 3/10/2016
NYU Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
Effect of Music on Attention and Prospective Memory in Hepatic Encephalopathy
Effect of Music on Attention and Prospective Memory in Hepatic Encephalopathy
Status: Enrolling
Updated:  3/10/2016
NYU Medical Center
mi
from
New York, NY
Effect of Music on Attention and Prospective Memory in Hepatic Encephalopathy
Effect of Music on Attention and Prospective Memory in Hepatic Encephalopathy
Status: Enrolling
Updated: 3/10/2016
NYU Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
Pharmacokinetic and Safety Study of Nab®-Paclitaxel (ABI-007) Plus Gemcitabine in Subjects With Advanced Pancreatic Cancer Who Have Cholestatic Hyperbilirubinemia
A Phase 1, Multicenter, Open-label, Dose-escalation Study to Investigate the Safety and Pharmacokinetics of Nab®-Paclitaxel (ABI-007) Plus Gemcitabine in Subjects With Advanced Pancreatic Cancer Who Have Cholestatic Hyperbilirubinemia Secondary to Bile Duct Obstruction
Status: Enrolling
Updated:  3/10/2016
Mayo Clinic Arizona
mi
from
Scottsdale, AZ
Pharmacokinetic and Safety Study of Nab®-Paclitaxel (ABI-007) Plus Gemcitabine in Subjects With Advanced Pancreatic Cancer Who Have Cholestatic Hyperbilirubinemia
A Phase 1, Multicenter, Open-label, Dose-escalation Study to Investigate the Safety and Pharmacokinetics of Nab®-Paclitaxel (ABI-007) Plus Gemcitabine in Subjects With Advanced Pancreatic Cancer Who Have Cholestatic Hyperbilirubinemia Secondary to Bile Duct Obstruction
Status: Enrolling
Updated: 3/10/2016
Mayo Clinic Arizona
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
Pharmacokinetic and Safety Study of Nab®-Paclitaxel (ABI-007) Plus Gemcitabine in Subjects With Advanced Pancreatic Cancer Who Have Cholestatic Hyperbilirubinemia
A Phase 1, Multicenter, Open-label, Dose-escalation Study to Investigate the Safety and Pharmacokinetics of Nab®-Paclitaxel (ABI-007) Plus Gemcitabine in Subjects With Advanced Pancreatic Cancer Who Have Cholestatic Hyperbilirubinemia Secondary to Bile Duct Obstruction
Status: Enrolling
Updated:  3/10/2016
Barbara Ann Karmanos Cancer Center
mi
from
Detroit, MI
Pharmacokinetic and Safety Study of Nab®-Paclitaxel (ABI-007) Plus Gemcitabine in Subjects With Advanced Pancreatic Cancer Who Have Cholestatic Hyperbilirubinemia
A Phase 1, Multicenter, Open-label, Dose-escalation Study to Investigate the Safety and Pharmacokinetics of Nab®-Paclitaxel (ABI-007) Plus Gemcitabine in Subjects With Advanced Pancreatic Cancer Who Have Cholestatic Hyperbilirubinemia Secondary to Bile Duct Obstruction
Status: Enrolling
Updated: 3/10/2016
Barbara Ann Karmanos Cancer Center
mi
from
Detroit, MI
Click here to add this to my saved trials
Pharmacokinetic and Safety Study of Nab®-Paclitaxel (ABI-007) Plus Gemcitabine in Subjects With Advanced Pancreatic Cancer Who Have Cholestatic Hyperbilirubinemia
A Phase 1, Multicenter, Open-label, Dose-escalation Study to Investigate the Safety and Pharmacokinetics of Nab®-Paclitaxel (ABI-007) Plus Gemcitabine in Subjects With Advanced Pancreatic Cancer Who Have Cholestatic Hyperbilirubinemia Secondary to Bile Duct Obstruction
Status: Enrolling
Updated:  3/10/2016
Charite -Universitätsmedizin Berlin
mi
from
Berlin,
Pharmacokinetic and Safety Study of Nab®-Paclitaxel (ABI-007) Plus Gemcitabine in Subjects With Advanced Pancreatic Cancer Who Have Cholestatic Hyperbilirubinemia
A Phase 1, Multicenter, Open-label, Dose-escalation Study to Investigate the Safety and Pharmacokinetics of Nab®-Paclitaxel (ABI-007) Plus Gemcitabine in Subjects With Advanced Pancreatic Cancer Who Have Cholestatic Hyperbilirubinemia Secondary to Bile Duct Obstruction
Status: Enrolling
Updated: 3/10/2016
Charite -Universitätsmedizin Berlin
mi
from
Berlin,
Click here to add this to my saved trials
Study of the Pharmacokinetics and Safety of Carfilzomib in Subjects With Advanced Malignancies and Hepatic Impairment
An Open-Label, Single Arm, Phase 1 Study of the Pharmacokinetics and Safety of Carfilzomib in Subjects With Advanced Malignancies and Varying Degrees of Hepatic Impairment
Status: Enrolling
Updated:  3/11/2016
Karmanos Cancer Institute
mi
from
Detroit, MI
Study of the Pharmacokinetics and Safety of Carfilzomib in Subjects With Advanced Malignancies and Hepatic Impairment
An Open-Label, Single Arm, Phase 1 Study of the Pharmacokinetics and Safety of Carfilzomib in Subjects With Advanced Malignancies and Varying Degrees of Hepatic Impairment
Status: Enrolling
Updated: 3/11/2016
Karmanos Cancer Institute
mi
from
Detroit, MI
Click here to add this to my saved trials
Study of the Pharmacokinetics and Safety of Carfilzomib in Subjects With Advanced Malignancies and Hepatic Impairment
An Open-Label, Single Arm, Phase 1 Study of the Pharmacokinetics and Safety of Carfilzomib in Subjects With Advanced Malignancies and Varying Degrees of Hepatic Impairment
Status: Enrolling
Updated:  3/11/2016
Duke Cancer Institute
mi
from
Durham, NC
Study of the Pharmacokinetics and Safety of Carfilzomib in Subjects With Advanced Malignancies and Hepatic Impairment
An Open-Label, Single Arm, Phase 1 Study of the Pharmacokinetics and Safety of Carfilzomib in Subjects With Advanced Malignancies and Varying Degrees of Hepatic Impairment
Status: Enrolling
Updated: 3/11/2016
Duke Cancer Institute
mi
from
Durham, NC
Click here to add this to my saved trials
Study of the Pharmacokinetics and Safety of Carfilzomib in Subjects With Advanced Malignancies and Hepatic Impairment
An Open-Label, Single Arm, Phase 1 Study of the Pharmacokinetics and Safety of Carfilzomib in Subjects With Advanced Malignancies and Varying Degrees of Hepatic Impairment
Status: Enrolling
Updated:  3/11/2016
Gabrail Cancer Center
mi
from
Canton, OH
Study of the Pharmacokinetics and Safety of Carfilzomib in Subjects With Advanced Malignancies and Hepatic Impairment
An Open-Label, Single Arm, Phase 1 Study of the Pharmacokinetics and Safety of Carfilzomib in Subjects With Advanced Malignancies and Varying Degrees of Hepatic Impairment
Status: Enrolling
Updated: 3/11/2016
Gabrail Cancer Center
mi
from
Canton, OH
Click here to add this to my saved trials
Study of the Pharmacokinetics and Safety of Carfilzomib in Subjects With Advanced Malignancies and Hepatic Impairment
An Open-Label, Single Arm, Phase 1 Study of the Pharmacokinetics and Safety of Carfilzomib in Subjects With Advanced Malignancies and Varying Degrees of Hepatic Impairment
Status: Enrolling
Updated:  3/11/2016
Tennessee Oncology, PLLC
mi
from
Nashville, TN
Study of the Pharmacokinetics and Safety of Carfilzomib in Subjects With Advanced Malignancies and Hepatic Impairment
An Open-Label, Single Arm, Phase 1 Study of the Pharmacokinetics and Safety of Carfilzomib in Subjects With Advanced Malignancies and Varying Degrees of Hepatic Impairment
Status: Enrolling
Updated: 3/11/2016
Tennessee Oncology, PLLC
mi
from
Nashville, TN
Click here to add this to my saved trials
Study of the Pharmacokinetics and Safety of Carfilzomib in Subjects With Advanced Malignancies and Hepatic Impairment
An Open-Label, Single Arm, Phase 1 Study of the Pharmacokinetics and Safety of Carfilzomib in Subjects With Advanced Malignancies and Varying Degrees of Hepatic Impairment
Status: Enrolling
Updated:  3/11/2016
Evergreen Hematology & Oncology
mi
from
Spokane, WA
Study of the Pharmacokinetics and Safety of Carfilzomib in Subjects With Advanced Malignancies and Hepatic Impairment
An Open-Label, Single Arm, Phase 1 Study of the Pharmacokinetics and Safety of Carfilzomib in Subjects With Advanced Malignancies and Varying Degrees of Hepatic Impairment
Status: Enrolling
Updated: 3/11/2016
Evergreen Hematology & Oncology
mi
from
Spokane, WA
Click here to add this to my saved trials